Logo

depression

Study Links Maternal Mental Illness-Related Variants to Perinatal Risk Factors For Offspring

Researchers identified relationships between pregnancy-related maternal traits and behaviors and polygenic risk scores for half a dozen mental health conditions.

Gut Microbiome Characteristics Tied to Depressive Symptoms in New Studies

Researchers profiled gut microbial community patterns in antidepressant-free individuals, identifying features linked to depressive symptoms.

Avera Health Publishes Clinical Validation of PGx Panel for Depression Treatment Optimization
Premium

The GeneFolio Pharmacogenomic Panel was developed by the Avera Institute for Human Genetics, a laboratory at the Sioux Falls, South Dakota-based health system.

Genetika+ Snags CE Mark for Major Depressive Disorder Drug-Matching Test

The NeuroKaire test predicts a patient's drug response by combining patient-reported information, pharmacogenetics data, and so-called "brain-in-a-dish" functional testing.

Genetika+ Combines PGx, 'Brain-in-a-Dish' Model to Personalize Depression Meds
Premium

The company wants to commercialize its first antidepressant-matching service in 2023 and is hoping to launch it as an LDT in the US. 

Jul 13, 2022

Family History Improves Polygenic Risk Scores for Complex Disease in Non-Europeans

Feb 14, 2022

Cardiometabolic Disease Shows Ties to Depressive Mood, Irrespective of Genetic Risk

Dec 15, 2021

Startup Circular Genomics Raises $4.5M in Seed Funding

Nov 24, 2021

Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort

Sep 30, 2021

Pharmacogenomics Firm Genetika+ Raises $10M in Series A Round

May 27, 2021

Large-Scale Depression Genetic Study Uncovers Additional Risk Loci, Ties to Potential Drugs

Apr 13, 2021

Proteome-Wide Association Study of Depression Homes in on Potential Treatment Targets

Mar 8, 2021

Case-Case GWAS Approach Identifies Loci That Differ in Frequency Across Psychiatric Disorders

Jan 19, 2021

Psychiatric Disorder Risk Affected by Dysregulation of RNA-Binding Proteins

Dec 2, 2020

Depression-Related Gut Microbiome, Metabolite Changes Lead to Potential Biomarker Set

Dec 2, 2020

Genetic Technologies Lands Distribution Rights to Taliaz Antidepressant Drug Selection Tools

May 14, 2020

Brain Proteins May Mediate Effects of Genetic Variants on Some Neurological Phenotypes

Apr 15, 2020

Childhood Mood, Behavioral Problems May Share Genetic Features With Some Adult Conditions

Mar 30, 2020

Depression GWAS Based on Minimal Phenotyping May Lead to Skewed Results

Mar 16, 2020

With $100M in New Funding, Tempus Targets Diseases Beyond Cancer
Premium

Mar 13, 2020

Tempus Closes $100M Series G Round

Jan 8, 2020

Psychiatric Disorders, Body Mass Index Share Genetic Loci, Study Finds

Dec 12, 2019

Psychiatric Disorders Fall Into Groups With Shared Genetic Contributors in GWAS Meta-Analysis

Nov 21, 2019

Intermountain Healthcare to Gather Utility Data as SelectHealth Covers PGx Test for Certain Employees
Premium

Sep 26, 2019

Mental Health Advocacy Groups Appeal to FDA to Reconsider PGx Enforcement Activity

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.